top
Search terms
Results 1 - 10 of 38 - ordered by :
Pages: 1 2 3 4
Ehjournal

Presently available treatment options are far from optimal and new insights into underlying mechanisms are needed to improve therapy. The objective of the present paper is to review the ...

European Heart Journal, Nattel, Stanley, Dobrev, Dobromir

Date : 01/08/2012
Ehjournal

[...]we do not have the means to prevent AF or AF-related complications adequately. [...]over 70 experts on atrial fibrillation convened for the 2nd AFNET/EHRA consensus conference to suggest ...

European Heart Journal, Kirchhof, Paulus, Bax, Jeroen, Blomstrom-Lundquist, Carina, Calkins, Hugh, Camm, A. John, Cappato, Ricardo, Cosio, Francisco, Crijns, Harry, Diener, Hans-Christian, Goette, ...

Date : 01/12/2009 Item size : 656742 bytes
Ehjournal

The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology. Presently available therapy for AF is ...

European Heart Journal, Nattel, Stanley

Date : 01/10/2005 Item size : 96100 bytes
Ehjcardiovascrec

In disease states, fibroblast production of increased quantities of ECM proteins leads to tissue fibrosis, which can impair both mechanical and electrical function of the heart, contributing to heart ...

Cardiovascular Research, Yue, Lixia, Xie, Jia, Nattel, Stanley

Date : 01/03/2011 Item size : 492471 bytes
Ehjournal

The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology. Presently available therapy for AF is ...

European Heart Journal, Nattel, Stanley

Date : 01/10/2005
Ehjournal

Beneficial effects of ACE-inhibitors on mortality and morbidity in CHF patients were demonstrated in early clinical trials.2,3 ACE-inhibition also diminishes ventricular arrhythmias after myocardial ...

European Heart Journal, Ehrlich, Joachim R., Hohnloser, Stefan H., Nattel, Stanley

Date : 01/03/2006 Item size : 210630 bytes
Ehjcardiovascrec

Furthermore, studies in humans suggest a protective role for HSPs against progression from paroxysmal AF to chronic, persistent AF. [...]manipulation of the HSP system may offer novel therapeutic ...

Cardiovascular Research, Brundel, Bianca J.J.M., Ke, Lei, Dijkhuis, Anne-Jan, Qi, XiaoYan, Shiroshita-Takeshita, Akiko, Nattel, Stanley, Henning, Robert H., Kampinga, Harm H.

Date : 01/06/2008
Ehjournal

See page 1427 for the editorial comment on this article (doi:10.1093/eurheartj/ehu099) Introduction Atrial fibrillation (AF) is commonly considered a progressive condition, whereby the arrhythmia ...

European Heart Journal, Nattel, Stanley, Guasch, Eduard, Savelieva, Irina, Cosio, Francisco G., Valverde, Irene, Halperin, Jonathan L., Conroy, Jennifer M., Al-Khatib, Sana M., Hess, Paul L., ...

Date : 07/06/2014
Ehjcardiovascrec

Atrial fibrillation (AF) is the most common sustained clinical arrhythmia, and is an increasing problem in terms of prevalence, complications, and health costs.1 The options for treating AF are ...

Cardiovascular Research, Nattel, Stanley

Date : 01/06/2016 Item size : 96539 bytes
Ehjcardiovascrec

Atrial fibrillation (AF), the most common sustained arrhythmia, is associated with substantial cardiovascular morbidity and mortality, with stroke being the most critical complication.1 Present drugs ...

Cardiovascular Research, Dobrev, Dobromir, Nattel, Stanley

Date : 01/03/2011 Item size : 158514 bytes